Amgen Ascends, Salesforce Struggles
As the opening bell chimed on Friday, Amgen took a stellar stride, becoming the standout performer among the Dow Jones Industrial Average constituents, with shares climbing a solid 1.0%. However, when viewing Amgen’s year-to-date trajectory, a less optimistic narrative unfolds, with a decrease in value by approximately 4.8%.
Salesforce, on the other hand, emerged as the bearer of bad news, the worst performer in the Dow component, sporting a 1.9% decrease in trading. Despite this daily downtrend, Salesforce displays a marked 13.0% uptick in its year-to-date performance.
Other Players in the Market
Accompanying this dynamic dance of the market movers are Amazon.com, experiencing a dip of 1.3% in trading, and Chevron, enjoying a moderate 0.8% increase for the day.
VIDEO: Dow Movers: CRM, AMGN
The insights expressed in this article represent the author’s perspective and do not necessarily correspond with those of Nasdaq, Inc.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
